BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galectin Therapeutics 

7 Wells Avenue, Suite #34

Newton  Massachusetts  02459  U.S.A.
Phone: 617-559-0033 Fax: 617-928-3450


SEARCH JOBS










 Company News
Galectin Therapeutics To Present At 7th Annual LD Micro Main Event Conference 12/4/2014 3:48:48 PM
Galectin Therapeutics Reports Third Quarter 2014 Financial Results And Provides Update On Company's Development Program 11/10/2014 8:04:41 AM
Galectin Therapeutics' Phase 1 Data Presented At American Association for Study of Liver Diseases Annual Meeting Advances GR-MD-02 Into Phase 2 Clinical Development 11/10/2014 7:26:20 AM
Galectin Therapeutics' Abstract Accepted As Oral Presentation At The Liver Meeting(R), Annual Meeting Of The American Association For The Study Of Liver Diseases 10/2/2014 7:44:27 AM
Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., A Leading Cancer Researcher, To Its Board Of Directors 9/24/2014 7:36:21 AM
Galectin Therapeutics Announces Issuance Of U.S. Patent For GR-MD-02 In Diabetic Nephropathy 9/15/2014 8:02:00 AM
Galectin Therapeutics To Present At Aegis Capital Corporation 2014 Healthcare And Technology Conference 9/10/2014 7:53:49 AM
Galectin Therapeutics Reports Second Quarter 2014 Financial Results 8/8/2014 10:53:36 AM
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 Composition Of Matter 8/5/2014 8:30:44 AM
Galectin Therapeutics Responds To Class Action Lawsuit 8/4/2014 8:13:51 AM
12345678910...